Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
Clinical trial NCT06569680 · RECRUITING
Trial details
- NCT number
- NCT06569680
- Sponsor
- Izidore Lossos, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-19
- Primary completion
- 2030-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.